We encourage the development of dual process models and measures to better understand
patient behavior, including behavior related to initiating biomedical prevention, choice of …

Pre-exposure prophylaxis (PrEP) is a once-daily pill prescribed by healthcare providers to
protect patients from contracting HIV. Current data suggests that a minority of healthcare …

Despite high levels of efficacy, the implementation of preexposure prophylaxis (PrEP) as a
strategy to prevent new HIV infection has been slow. Studies show that PrEP works so long …

Background and objectives Less than 10 percent of the more than one million people
vulnerable to HIV are using pre-exposure prophylaxis (PrEP). Practitioners are critical to …

Background: One barrier to wider preexposure prophylaxis (PrEP) availability is uncertainty
about the most appropriate providers and practice settings for offering PrEP. Methods: The …

Pre-exposure prophylaxis (PrEP) is a highly effective biobehavioral strategy for preventing
HIV acquisition. Although PrEP uptake has increased steadily, discontinuation rates are high …

The Health Belief Model has been useful for studying uptake of HIV prevention behaviors
and has had limited application to understanding utilization of pre-exposure prophylaxis …

Uptake of and persistence on pre-exposure prophylaxis (PrEP) in the United States have
been limited. The potential of new PrEP modalities to increase access will be hindered if …

Pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy. There is little
scientific consensus about how to measure PrEP program implementation progress. We …

Abstract Background Pre-exposure prophylaxis (PrEP) treatments reduce the risk of
contracting human immunodeficiency virus (HIV). However, despite proven effectiveness …